Clinical trials sponsored by Rambam Health Care Campus
3
Recruiting trials
8
Conditions studied
Phase breakdown
Early Phase 1 1Phase 2 2
Conditions studied
| Condition | Trials |
|---|---|
| Biological Substance; Adverse Effect | 1 |
| Breast cancer | 1 |
| Crohn's Disease Relapse | 1 |
| Crohn's disease | 1 |
| Fibromyalgia | 1 |
| Hyperglycemia Drug Induced | 1 |
| Hyperinsulinism | 1 |
| Metastatic Breast Cancer | 1 |
Recruiting trials led by Rambam Health Care Campus
- A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
- Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia
- Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Common questions
How many trials is Rambam Health Care Campus recruiting for?
Rambam Health Care Campus is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.